Your session is about to expire
← Back to Search
Arm C1 for Obesity (COURAGE Trial)
COURAGE Trial Summary
This trial is testing two new drugs, trevogrumab and garetosmab, along with a drug called semaglutide (Wegovy®), in both healthy participants and
COURAGE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOURAGE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COURAGE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the eligibility criteria for participating in this research trial?
"- At the initial assessment,"
Are there any available vacancies for potential participants in this research study?
"The ongoing search for eligible participants is detailed on clinicaltrials.gov. This investigation was initially disclosed on March 13, 2024 and recently revised on March 20, 2024."
What is the level of safety associated with Arm C0 for individuals involved in the trial?
"In this Phase 2 trial, Arm C0's safety was rated a 2 by the team at Power. This indicates some existing data supporting its safety profile but lacking evidence of efficacy."
Are participants above the age of 40 eligible for enrollment in this research investigation?
"Applicants aged between 18 and 80 years old are eligible for this study. Notably, there is a wealth of clinical studies available specifically for individuals under the age of 18 (178 trials) as well as those over 65 (646 trials)."
What is the total number of individuals participating in this clinical investigation?
"A total of 624 eligible individuals are sought to partake in this research. Potential participants can engage from various locations, including Tandem Clinical Research in Marrero, Louisiana and Accellacare of Wilmington in Wilmington, North carolina."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Tandem Clinical Research, Marrero: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger